Every super-investor and insider move tracked across 37 tickers in this industry.
| # | Manager | Sector value |
|---|---|---|
| 1 | BlackRock | $17.55B |
| 2 | Howard Marks Oaktree Capital | $8.83B |
| 3 | Dodge & Cox | $4.11B |
| 4 | Wellington Management | $3.26B |
| 5 | Norges Bank Norway SWF | $2.80B |
| 6 | Renaissance Technologies | $2.01B |
| 7 | T. Rowe Price | $1.83B |
| 8 | AQR Capital Management | $1.39B |
| 9 | Ken Griffin Citadel Advisors | $905M |
| 10 | D.E. Shaw & Co. | $864M |
| 11 | Izzy Englander Millennium Mgmt | $758M |
| 12 | Larry Robbins Glenview Capital | $660M |
| # | Ticker | Company | Value |
|---|---|---|---|
| 1 | BHC | BAUSCH HEALTH COS INC | $9.44B |
| 2 | ZTS | ZOETIS INC | $7.51B |
| 3 | UTHR | UNITED THERAPEUTICS CORP DEL | $6.31B |
| 4 | NBIX | NEUROCRINE BIOSCIENCES INC | $4.31B |
| 5 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $4.08B |
| 6 | ELAN | ELANCO ANIMAL HEALTH INC | $3.25B |
| 7 | VTRS | VIATRIS INC | $2.62B |
| 8 | HLN | HALEON PLC | $1.98B |
| 9 | HIMS | HIMS & HERS HEALTH INC | $1.22B |
| 10 | PBH | PRESTIGE CONSMR HEALTHCARE I | $869.2M |
| 11 | LNTH | LANTHEUS HLDGS INC | $853.4M |
| 12 | SUPN | SUPERNUS PHARMACEUTICALS INC | $845.7M |
| 13 | COLL | COLLEGIUM PHARMACEUTICAL INC | $385.3M |
| 14 | AMRX | AMNEAL PHARMACEUTICALS INC | $365.5M |
| 15 | PCRX | PACIRA BIOSCIENCES INC | $339.0M |
| 16 | ANIP | ANI PHARMACEUTICALS INC | $326.8M |
| 17 | LQDA | LIQUIDIA CORPORATION | $310.2M |
| 18 | RDY | DR REDDYS LABS LTD | $284.3M |
| 19 | BCRX | BIOCRYST PHARMACEUTICALS INC | $276.6M |
| 20 | AMPH | AMPHASTAR PHARMACEUTICALS IN | $195.1M |
| 21 | PAHC | PHIBRO ANIMAL HEALTH CORP | $181.1M |
| 22 | TAK | TAKEDA PHARMACEUTICAL CO LTD | $180.9M |
| 23 | HROW | HARROW HEALTH INC | $153.6M |
| 24 | ESPR | ESPERION THERAPEUTICS INC NE | $138.1M |